Group-Based Pain Management Program Content.
Open access peer-reviewed article
This Article is part of Healthcare information; Medical Devices Section
Article metrics overview
306 Article Downloads
View Full Metrics
Article Type: Research Paper
Date of acceptance: February 2023
Date of publication: April 2023
DoI: 10.5772/dmht.15
copyright: ©2023 The Author(s), Licensee IntechOpen, License: CC BY 4.0
Introduction Telehealth pain management has become instrumental in managing patients with chronic pain (CP) since the onset of the COVID-19 pandemic. The primary aim of this study was to investigate whether various covert therapeutic variables aid in the efficacy of telehealth group-based pain management programs (GPMPs). The therapeutic alliance (TA), group dynamics (GDs), attendance and change in pain neuroscience knowledge were evaluated as potential predictor covert variables of change in pain outcome measures and readiness to change (RTC) maladaptive pain behaviors. Methods Telehealth GPMP groups met once a week for 3 hours via zoom software and ran over a course of 6 weeks in which CP self-management techniques were taught. Pain outcome measures were taken at baseline and after the final telehealth GPMP. In addition, the measures around pain neuroscience understanding were examined at baseline and post-intervention. Finally, the TA and GDs were examined at post-treatment using the Therapeutic Group Context Questionnaire (TGCQ). Various statistical procedures were utilized to determine the predictive nature between the specific variables. Results The TA and GDs showed statistically significant ( p < 0.05) predictive relationships with improved changes in maladaptive pain behaviors and pain self-efficacy. There was also a statistically significant ( p < 0.05) predictive relationship between maladaptive pain behavioral changes and improvements in pain self-efficacy, pain catastrophizing and pain kinesiophobia. Discussion This research suggested that covert components in a telehealth GPMP such as changes in readiness to change (RTC) maladaptive pain behaviors, the TA, and GDs are all strong predictors of improvements in pain outcome measures following such an intervention.
telehealth
group-based pain management programs
chronic musculoskeletal pain
therapeutic alliance
group dynamics
Author information
The Global Burden of Disease Study 2016 highlights the prominence of pain and pain-related diseases and disorders as the foremost cause of disability and disease burden globally [1]. In 2016, the Centers for Disease Control and Prevention (CDC) analyzed the National Health Interview Survey (NHIS) data to estimate the occurrence of chronic pain (CP) in the USA; an estimated 20.4% (50 million) of US adults suffered from CP and 8% of US adults (19.6 million) had high-impact CP [2]. These figures highlight the need for greater access to interventions that target CP. Chronic musculoskeletal pain, a multifaceted experience, has substantial consequences on patients themselves, as well as on their families, relationships, social and professional lives, and ultimately causes a decline in quality of life (QOL) for both the patients and their families [2, 3]. Group-Based Pain Management Programs (GPMPs) have been found to aid patients with self-management approaches for CP [4, 5].
Research, in the recent past, has advocated for an examination into wider treatment factors related to GPMPs, however, there are limited studies and insights into this critical area of interest [3]. In particular, therapeutic contextual factors (TCFs), such as the therapeutic alliance (TA) and group dynamics (GDs) have received little attention within pain research and clinical practice [4], specifically within telehealth GPMPs, necessitating a need for further exploration in this area. With the onset of COVID-19 at the beginning of 2020, in-person access to pain management programs was and still is widely reduced, for which reason telehealth and therefore, the exploration of telehealth GPMPs in particular is warranted.
A treatment is never administered in a neutral environment, but rather in a multifaceted composite of TCFs [5], that have cognitive neuroscientific effects on patients with all health problems including CP. These effects powerfully influence outcomes and are consequences of the brain-mind responses (i.e. potentially placebo mechanisms) to the
Group therapy fulfills a supportive role by permitting disclosure of thoughts and feelings to others who have mutual circumstances, which in turn leads to a heightened sense of legitimacy for the patient, internal locus of control and therefore allows for peer group support and encouragement [8, 9]. Newton-John and Geddes [1] add that the effects taking place in a group pain management program are more diverse and complex than solely positive regard from the therapist and mutual sharing of experiences by group members [10]. Yalom (1995; cited in Newton-John and Geddes [1]) suggests that ‘group cohesiveness’ is the main curative factor in group therapy [1]. Group cohesiveness encompasses shared experiences and goals, mutual respect, acceptance, supportive feedback and interaction, reality testing, and vicarious learning [1]. Patients in groups can gain from sharing their common experiences, monitoring/observing each other, and expressing themselves in a safe and non-threatening atmosphere [1]. The above confirms the ideas around social observational learning theories, additionally highlighting the significant impact that group-based intervention can have on patients with CP through matters underlying the entity of group dynamic factors. Ultimately, in opposition to a lay leader, “… when a skillful practitioner uses the group process to move clients beyond mutual empathy and toward regaining of function, a crucial component of the psychosocial treatment for chronic pain is served” (Thorn and Kuhajda [2], p. 1356]).
Modern learning theories understand learning as a result of changes in behavior that take place as a consequence of patterns in an individual‘s environment [3, 4]. Therefore, the therapeutic environment including GDs within a GPMP should be taken into account when examining subjects‘ potential changes in behavior based on the therapeutic contextual environment. Behavior, in the above description, refers to both observable deliberate and automatic responses or neuronal activity (brain activity) [3, 4]. This notion is in keeping with the pivotal work of Albert Bandura, the foremost theorizer, and writer of this theory [4]. Bandura defined observational learning as “changes in patterns of behavior that are a consequence of observing the behavior of others” (Goubert
The recent development of The Therapeutic Group Context Questionnaire (TGCQ) allows researchers and clinicians to evaluate how subjects in telehealth GPMPs perceive the amount that the TA and GDs has on their overall pain experience [8]. This questionnaire has been shown to be a valid and reliable instrument for subjects with CP, as assessed through telehealth GPMPs [8].
As well as the strong need for GPMPs, recent meta-analytic studies that we have conducted and published, display the strong need for therapeutic pain neuroscience education (TPNE) in pain management intervention [9, 10]. TPNE is a treatment modality used in pain management so to enhance patients’ knowledge and understanding of the underlying pain processes and mechanisms [11]. By doing so, it is suggested that clinicians are able to reduce negative cognitions of patients with CP, such as the threat and fear value of pain [11]. Therefore, investigating subjects‘ pain knowledge and changes in pain physiology knowledge through our study`s telehealth GPMP intervention, was a core factor to aid in understanding whether or not subjects‘ changes in pain neuroscience knowledge predicts positive pain outcomes, following telehealth GPMPs.
Finally, attendance/adherence to the telehealth GPMPs was another variable we considered as a potential predictor of pain outcomes following intervention. Lack of independent function, as one possible example for the reason behind lack of attendance, has been shown to be a barrier for some CP patients arriving for their pain management programs [12, 13]. The inability to attend sessions on a regular basis might in fact possibly fall under exclusion criteria, as these subjects might not get the full benefit from in-person GPMPs. However, our current study being telehealth in nature, potentially may reduce these barriers and thus have an impact on the overall outcomes of our intervention.
Therefore, the purpose of this study was to examine if these ‘covert ingredients/factors/variables‘ (baseline pain neuroscience knowledge, relational TCFs, and attendance of sessions) in telehealth GPMPs, predict change in Readiness to Change (RTC) maladaptive pain behaviors and change in subjects` pain neuroscience knowledge. In addition, the study aimed to assess if specific components (therapeutic relational contextual factors and attendance of sessions) of telehealth GPMP interventions are related to change in pain outcome measures.
The target population for this study was patients with chronic musculoskeletal pain (localized anywhere in the body or widespread). The sampling process was non-probability sampling based on convenience, and subjects were placed into a single treatment group. Based on the COVID-19 crisis and social distancing parameters at the time, the research aimed to examine telehealth GPMPs through the use of Zoom software (Zoom Video Communications, San Jose California, USA ). Therefore, there were no geographic restrictions as to where subjects were recruited from, and thus subjects were recruited from different countries. All included subjects were placed in the treatment group consisting of 5 separate GPMPs. The aim was to have between 8 to 12 subjects in each GPMP.
The intervention was carried out through a telehealth format (Zoom software). Each group received the exact same treatment. The telehealth GPMPs included 6 sessions (1 session a week), and for approximately 3 hours per session. Prior to the first session (1–2 days prior to the 1st session), participants were required to complete online, via Qualtrics (
Content within (Telehealth) Group-Based Pain Management Program: Discussions and Sessions: |
General group Introduction: Ice-breakers |
∙ Subjects introduce themselves |
∙ Clinician introduced himself/herself |
∙ Outline of aims of the program |
∙ Shared Group goals |
∙ Agreed upon group-rules |
Impact of Pain on individuals’ lives: Biopsychosocial impact |
Pain cycles and activity cycles: over and under activity leading to ‘Boom and Bust’ idea |
Changing Maladaptive Pain Behaviors |
SMART goal setting: Short-term, medium-term and long-terms goal setting |
Pain diaries: Yes or No? |
Therapeutic Pain Neuroscience Education (TPNE): What is pain? |
The importance of exercise and movement: exercise and movement principles for chronic pain |
Graded Activity, Graded exposure and Pacing: Use to achieve SMART goals without flaring up pain |
Thoughts, Feelings and Behavior: Cognitive Behavioral therapy (CBT) and Dialectical Behavioral Therapy (DBT); Challenging unhelpful thoughts |
Psychological relaxation/stress management exercises and techniques; including mindfulness, meditation and other relaxation exercises |
Flare-Up Management |
Diet and Chronic Pain |
Other topics and questions that group members requested to be covered through the course of the program |
Notably, this is not an all-inclusive list but rather core topics that were required for each group in the program. At the beginning of each session following session 1, subjects were provided with the opportunity to summarize their week and how their use of the tools taught to them in the previous session went. They also had the opportunity to ask questions at which point the clinician was able to answer the questions and/or other group members aided in facilitating the answers. A PowerPoint (PPT) presentation was used to navigate each session in combination with a supplementary pain management manual for each subject, which has been developed over many years by the primary author of this paper. The manual was designed to consolidate subjects‘ knowledge and tools around self-management strategies. The manual also incorporated homework tasks for the subjects to undertake between sessions so as to practice various skills that had been taught to them during the weekly get-together sessions. To note, when it came to the exercise education component in each week‘s session (5–10 min in each session), subjects were to undertake this in the space that they were located in by observing what the clinician was doing on the screen. Although this might have been a potential barrier, the actual exercise sessions were not created to act as a specific treatment modality as part of the GPMPs. Rather, the exercise component was instituted to merely educate subjects on how to exercise with CP and potentially reduce their likely fear-underpinning exercise through graded exposure, graded activity, and pacing techniques. At the end of the final session (1–2 days following the last session) each subject was again required to complete the same outcome measures that were used at baseline, but this time the TGCQ was also incorporated to address the TA and GDs.
Prior to the start of the intervention, baseline pain outcome measures were completed by the subjects. These included: Pain Stages of Change Questionnaire (PSOCQ), Pain Self-Efficacy Questionnaire (PSEQ), the Pain Catastrophizing Scale (PCS), the Tampa Scale of Kinesiophobia (TSK), the Short Form Health Survey −36 (SF-36) Total, and the Visual Analogue Scale (VAS). The primary outcome measures for this study were pain self-efficacy, pain catastrophizing, and kinesiophobia. The secondary outcome measures for the purpose of this study were the VAS and SF-36-Total. Change in the pain outcome scores from pre-to post-intervention were considered the dependent variables (DVs) in this study. Score results for the pain outcome questionnaires suggest the following: Lower scores on the VAS, PCS-Total and TSK suggest less pain intensity, less pain catastrophizing and less kinesiophobia respectively, and thus change in scores (pre-intervention scores subtracted from post-intervention scores) with a negative value represent an improvement in these three outcome measures. Higher scores on the PSEQ, and SF-36 Total suggest greater pain self-efficacy and greater QOL and therefore change in scores (pre-intervention scores subtracted from post-intervention scores) with positive values suggest improvements in these two outcome measures results. The PSOCQ was used to determine the RTC stage for each subject. The PSOCQ, is based on the transtheoretical model (TTM) of behavior change, which stipulates that individuals move through discrete “stages-of-change” when altering maladaptive pain behaviors [13, 14]. Analysis of the PSOCQ reveals four distinct scales that reflect upon the TTM of behavior change: (1) “
The maximum sessions that were allocated to each telehealth GPMP was 6 sessions. Therefore, attendance was recorded for each subject as a continuous variable, to use within the analyses of this study.
Relevant tests for normality of distribution of the outcome measures’ data for pre-post-test changes in the primary and secondary pain outcome measures, RNPQ, TGCQ scores and change PSOCQ-Action scores, were first conducted. In addition, underlying assumptions for each statistical test were also examined before conducting the specific statistical examinations.
For the Pearson‘s correlation coefficient values, a magnitude (−1 to +1) and significance or lack thereof amongst the relationships was noted. In terms of strength of the relationship, 0.7 iwas considered strong, between 0.5 and 0.7 was moderate in strength and less than 0.4 was a weak or no correlation. Based on Pearson‘s correlation coefficients that displayed statistically significant results, multiple linear regression was used for the DVs that had more more than one IV significantly correlated with it. The regression analyses were conducted to examine whether or not there was a predictive relationship between the variables at hand.
To reiterate examining the change in scores, pre-treatment scores were subtracted from post-treatment scores. A positive mean difference for PSEQ, SF-36, and PSOCQ-Action subscale, and a negative mean difference for VAS, PCS-Total, TSK, and RNPQ represented an improvement in these outcome measures.
A total of 42 participants, 33 female patients and nine male patients were included in this study. The mean age was 51.47 years and subjects were from multiple countries. The mean duration that patients had pain was 15.30 years.
A summary of various descriptive statistics is presented in Table 2.
The assumptions were met to carry out Pearson‘s Correlation Coefficient analyses. A summary of the correlations are presented in Table 3 and the statistically significant correlations (
All the assumptions underlying the use of multiple regression analysis were met except for collinearity and therefore, the multiple regression analysis should be interpreted with caution. The collinearity assumption was violated for TGCQ-Total score with each of its sub-measures; TGCQ-TA and TGCQ-GD. The TGCQ-Total score was included in the analysis as there was statistically significant correlation found initially for the total score under Pearson‘s Correlation Coefficient analysis (Table 3). In addition, the total score captures the group therapeutic contextual experience on a broader level. However, attendance did not appear to have multicollinearity problems. Multiple linear regression was completed for the DV of change in PSOCQ-Action scores (used to measure change in maladptive pain behaviors), as this variable displayed statistically significant correlations with the IVs: TGCG-Total, TGCQ-TA, TGCQ-GD and attendance. Table 4 summarizes the multiple regression results. As noted in Table 4, there were no statistically significant predictor variables (IVs) in the model, however the model‘s overall relationship between the DV and the IVs was statistically significant (
A summary of various descriptive statistics is presented in Table 5.
The assumptions, once again, were met to carry out Pearson‘s Correlation Coefficient analyses. Table 6 summarizes all the Pearson‘s Correlation results with regard to the associations between therapeutic relational factors (TGCQ-Total, TGCQ-TA and TGCQ-GD), and attendance with change in scores for all pain outcome measures. Notably, the PSEQ (one of the primary outcome measures in this study) change in scores as the DV was statistically significantly associated with the therapeutic relational scores but not attendance of sessions;
All the assumptions underlying the use of multiple regression analysis were met except for collinearity and therefore, the multiple regression analysis should be interpreted with caution. The collinearity assumption was violated as there was cross-over between the TGCQ-Total score with each of its sub-measures; TGCQ-TA and TGCQ-GD. Multiple linear regression was completed for the DV of change in PSEQ scores with the TGCQ-Total, TGCQ-TA and TGCQ-GD-Action scores, as these IVs were all statistically significantly correlated with change in PSEQ scores. Table 7 reveals an overall model correlation of r = 0.52 (positive and moderate in magnitude) with all the variables, noted above, entered into the model. In addition, the total model was statistically significant (
Descriptive statistics in terms of changes in the pain outcome measures are reflected in Table 5, and changes in the PSOCQ-Action sub-measure and RNPQ are shown previously in Table 2.
Once again, the assumptions were met to carry out
All assumptions underlying simple linear regression for the variables being the PSEQ change in scores (DV) and PSOCQ-Action change in scores (IV) were met. The R-squared value for the PSEQ change in scores with the PSOCQ-Action change in scores was 0.35 suggesting that the IV explained 35.0% of the variance in the DV. The overall model had a F-value of 21.70 and was statistically significant (
Multidisciplinary pain management programs, based on biopsychosocial principles, formed the foundation underlying the telehealth GPMPs used in this study. The above biopsychosocial model has been found in previous studies to most likely enhance patients‘ overall Quality of Life (QOL) as well as general well-being [15, 16]. This was once again noted in the current research. Strand
The current study aimed to find the best predictor/s for change in the PSOCQ-Action scores through telehealth GPMPs. Jensen
Previous meta-analytic research has demonstrated the positive impact that in-person GPMPs can have on multiple pain outcome measures following intervention [9]. Although the aforementioned meta-analysis did not include RTC maladaptive pain behaviors as a potential outcome measure, the study still supports the use of telehealth GPMPs (based on the statistically significant results including the TGCQ-GD sub-measure) when it comes to managing CP. Further research has demonstrated the importance of patient expectations and the TA within group-based cognitive behavioral therapy for insomnia [21]. The current research intervention, performed by the primary author, incorporated group-based CBT treatment to help manage subjects’ CP symptoms including sleep. The current research suggested that all pain outcome measures improved from pre-treatment to post-treatment.
This particular study suggests that changes in RTC pain behaviors (PSOCQ-Action scores), through telehealth GPMPs, seem to produce statistically significant changes in pain self-efficacy, pain catastrophizing, and pain kinesiophobia. Higher levels of pain self-efficacy, specifically related to greater relational TCFs such as the TA and GDs, have been found to be associated with improved pain outcomes [22]. The present research also suggests that changes in pain self-efficacy had a statistically significant predictive relationship with all the TGCQ measures (TGCQ-Total, TA, and GD); relational TCFs predict, specifically, better pain self-efficacy outcomes following telehealth GPMPs. Stronger emotional well-being has been found to improve pain outcome measures [23–25]. Greater pain self-efficacy may be hypothesized to represent and be associated with overall better emotional well-being. Potentially, a greater TA and GDs may improve pain self-efficacy through subjects‘ perceptions of heightened emotional and physical support via the clinician and the group as a whole. In addition, as the results of the study suggest, changes in RTC predict greater changes in pain self-efficacy. If an individual becomes more RTC through pain management intervention, then pain self-efficacy potentially improves as a consequence. This association may be the result of CP subjects feeling more empowered to take on more self-management of their symptoms and therefore their internal locus of control improves, thus strengthening their self-efficacy relating to their pain. A previous review has suggested that effective coping and self-management rely on self-efficacy beliefs [26], and therefore the above association may be clinically relevant to subjects with CP. Evidence has speculatively revealed that observational learning appears to have a significantly large impact on the attainment and treatment of pain behaviors (Craig, 1986 cited in Goubert
Social support and observational learning, via group-based programs and TA, such as in the current study, have been shown to contribute to placebo analgesic effects [27]. The results of this study suggest that GDs, as measured through the TGCQ-GD sub-measure, in a telehealth GPMP is significantly associated with improvements in pain kinesiophobia. According to the social observational learning theory model, placebo analgesic effects can be learned through observations of other patients having an analgesic response to a particular treatment [6, 28–30]. Treatments for which this has been observed include medication, invasive treatment, manual treatment, exercise, cognitive behavioral treatment, and other psychoeducational treatments for CP. Based on previous social learning theory work by Albert Bandura, Bajcar, and Babel [30], outlines a model of social observational learning that explains the mechanisms and factors relating to observational learning, that contributes to placebo analgesic effects [30]. In addition, the model importantly includes the role of expectancies and the individual characteristics of the observing subject in the production of placebo analgesia as well as nocebo hyperalgesia brought on by social observational learning [30]. Thus, the notion of witnessing other patients having an improvement in their pain symptomology and in turn a reduction in the observer‘s symptomology [29–33], should stimulate the topic around the positive effects of GPMPs, and therefore further use of GPMP intervention. This should include telehealth GPMPs as evidenced by the positive results of this current research. Learning can be achieved through observation and replication of others‘ behavior patterns [34]. As for kinesiophobia specifically, based on the results of this study, it is suggested that subjects witnessing other subjects in their group having less fear to move encourages other subjects to move with less threat via social observational learning theory mechanisms, as was seen in the present study.
The results in this analysis correspond to the results of a previous meta-analysis that was recently published where in-person GPMPs acted as a statistically significant moderator on pain outcomes based on Therapeutic Pain Neuroscience Education (TPNE) [10]. TPNE, a modality used within our telehealth GPMPs, results in advantageous clinical effects, where the intervention is provided to a group of patients with diverse CP conditions [9, 10, 35]. The meta-analysis mentioned above focused on the efficacy of TPNE on pain outcome measures and demonstrated that TPNE has an overall beneficial effect on subjects‘ pain following such intervention [10]. However, the current telehealth GPMP research did not support the results of previous in-person GPMP studies. It may be hypothesized that TPNE provided within in-person GPMPs is more efficacious than TPNE provided in telehealth GPMPS. This result may be due to a potentially stronger TA built within in-person GPMPs and potentially easier to explain pain neuroscience to subjects with CP when in-person rather than via a telehealth format. Previous research, based on outpatient in-person pain management, found that the program favorably affected motivation to change and in turn impacted positively on subjects‘ QOL [36]. This was also evidently reflected in the results of the current study despite being telehealth in nature. Overall QOL, assessed via the SF-36 Total, encompasses a biopsychosocial model of pain, in which the physiological, psychological, and social effects of CP were evaluated. Therefore, through this research, it is suggested that telehealth GPMPs, through using TPNE as one of the treatment modalities, can aid in improving subjects‘ lives in a holistic manner.
Adherence to following through with the treatment skills taught in pain management programs incorporates self-report, behavioral (including attendance of sessions), and clinical outcomes [37]. Patient education and motivation, including TPNE and other treatment modalities within a pain management program (PMP), play essential roles in engaging patients in the self-management of their CP [38]. In addition, self-management is catalyzed further by the patient-healthcare provider communication process [38]. Patients’ adherence and attendance to PMPs, seem to become stronger through more solid and positive provider-patient relationships [38].
The current study showed a statistically significant correlation between attendance of sessions and the magnitude of change in PSOCQ-action scores. Attendance of sessions was high for the majority of subjects through this study with the mean attendance being 5.45 and the mode being 6 (maximum telehealth sessions was 6 sessions). Apart from implementing in their everyday lives the materials and techniques taught through the pain management sessions, attendance of sessions may play a key role in the improvement of the pain outcome scores through improved RTC. Most subjects in this research attended the majority of their prescribed sessions. Pain practitioners commonly face challenges concerned with noncompliance with directed clinical guidance and nonadherence (lack of attendance) to pain management treatment plans whether non-pharmacologically based or medication based [37]. Previous research has demonstrated that patient engagement and attendance to pain management sessions correlate with improved pain outcomes and are additionally influenced by the clinician-patient relationship [37, 38]. Thus, potentially as a result of the high attendance of sessions in this telehealth study, the overall effectiveness of the intervention may be partly associated with the attendance of sessions. The above factors suggest patients should attend all if not most of the GPMP sessions, and in turn further instill pain self-management strategies to further enhance subjects' benefits from PMPs, such as evidenced in the current telehealth GPMPs research.
A previous meta-analysis, as well as other research, has found that there was a moderate but reliable relationship between a good TA and positive therapeutic outcomes for psychotherapy [39–43]. To note, pain management intervention should include psychological intervention, specifically when it comes to managing patients‘ anxiety, stress, and depression levels. The TA, in a previous systematic review, was found to produce better exercise adherence in musculoskeletal physical therapy [44]. The current study found that the TA was associated with overall improvements in pain outcome measures, specifically pain self-efficacy changes as described previously. Of interest, it has been established that clinician variability in the alliance is suggested to be more important than patient variability, for superior patient pain outcomes [45].
The multiple regression analysis when assessing the model of change in PSOCQ-Action scores as the DV and the TGCQ-Total, TGCQ-TA, and TGCQ-GD as the IVs, should be interpreted with caution. The inflated collinearity factors, at certain points in the analyses, such as the Variance Inflation Factor (VIF) and tolerance, were at times slightly outside the normal range. Therefore, the assumption for collinearity was questionable at times. This may be the result of the various TGCQ scores (the 3 IVs) all being related, as they come from the same instrument. A modest sample size may have resulted in various outcome measures not showing statistically significant results based on the predictive models and this may be due to a type 2 error.
Future research should potentially examine at which point in time during a telehealth or in-person GPMP, that changes in PSOCQ-Action scores take place. In addition, it may be useful to gain insight into which part/s of a GPMP produces the changes in their RTC scores. Implementing a control group in future studies would possibly help further enhance the clarity around the specific active component predictor variables within a telehealth or in-person GPMP, that determine changes in RTC, changes in pain science knowledge, and ultimately changes in various pain outcome measures.
Finally, comparing telehealth versus in-person GPMPs would be an informative task to complete. Comparing these 2 formats with respect to various overt (active) and covert treatment variables and modalities in the actual intervention that predicts various outcome measures, such as the use of TPNE, would also be a useful task. Completing the above would potentially give further insight into the strength of the predictor variables, which potentially depend on the format of the GPMPs.
Making a positive change in maladaptive pain behaviors is what motivates most healthcare professionals involved in pain management [46]. Only through appropriate assessment, can we establish whether TPNE has truly made a difference to patients [46]. The research suggested that what might be understood as `covert` components in a telehealth GPMP such as the TA, GDs, and, RTC behavior are all predictors of pain outcome measures following such an intervention. Therefore making a stronger effort in clinical practice when using GPMPs to use these therapeutic tools, specifically building an enhanced TA and working with the group of patients to form tightened GDs, whether in-person GPMPs or through telehealth formats, should be encouraged in order to further improve the overall QOL in patients with CP conditions.
There are no additional acknowledgements to be made.
The authors declare no conflict of interest.
No sources of external support or funding.
Written by
Article Type: Research Paper
Date of acceptance: February 2023
Date of publication: April 2023
DOI: 10.5772/dmht.15
Copyright: The Author(s), Licensee IntechOpen, License: CC BY 4.0
© The Author(s) 2023. Licensee IntechOpen. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Impact of this article
306
Downloads
594
Views
3
Crossref Citations
3
Dimensions Citations
Join us today!
Submit your Article